Skip to main content
Premium Trial:

Request an Annual Quote

Two Blades Licenses TAL Code Technology to Dupont Pioneer

NEW YORK (GenomeWeb News) – The Two Blades Foundation today announced a licensing agreement with Dupont Pioneer providing it access to 2Blades' TAL Code technology for commercial use in certain crop plants.

The licensed technology enhances Dupont Pioneer's ability to further develop advanced plant genetics, the foundation said. In return, Dupont Pioneer will provide 2Blades access to improvements it makes to the TAL Code technology for use in 2Blades' humanitarian efforts to support sustainable farming.

Financial and other terms of the agreement were not disclosed.

The TAL Code technology was discovered by researchers at Martin-Luther University in Halle, Germany and is based on novel sequence-specific DNA binding proteins that may be designed for the recognition of almost any sequence of interest. The Two Blades Foundation has exclusive rights for commercial use of the technology in plants and has licensed it to a number of partners, including most recently Monsanto and KWS SAAT.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.